Literature DB >> 16895275

Race and medication adherence in Medicaid enrollees with type-2 diabetes.

Rahul A Shenolikar1, Rajesh Balkrishnan, Fabian T Camacho, J Timothy Whitmire, Roger T Anderson.   

Abstract

OBJECTIVE: The association of medication adherence with race has been inadequately studied previously in type-2 diabetes patients. The study objective was to determine the association between race and medication adherence among type-2 diabetes patients.
METHODS: This was a retrospective cohort study, which compared medication adherence among different races of Medicaid insured patients with type-2 diabetes newly starting oral antidiabetic medication. A total of 1,527 African-American patients newly starting antidiabetic medication between July 2001 and June 2002 were compared with 1,128 white patients and 514 patients of other race. Medication adherence was measured as medication possession ratio using prescription refill patterns. Multivariate regression analyses were used to determine the difference in adherence rates adjusting for other covariates.
RESULTS: Medication adherence rate was significantly higher for whites [0.59 (0.31)] as compared to African Americans [0.54 (0.31), (p<0.05)]. In multivariate analyses, the adherence rate of African-American patients was found to be significantly lower by 12% as compared to whites after adjusting for other covariates. Metformin users were associated with a 62% decrease in adherence rate as compared with the sulfonylureas group (p<0.05).
CONCLUSION: The antidiabetic medication adherence was associated with race. Future research should investigate patient-related factors affecting medication adherence in type-2 diabetes patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895275      PMCID: PMC2569450     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  23 in total

1.  Impact of dosage frequency on patient compliance.

Authors:  A H Paes; A Bakker; C J Soe-Agnie
Journal:  Diabetes Care       Date:  1997-10       Impact factor: 19.112

2.  The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

Authors:  A F Amos; D J McCarty; P Zimmet
Journal:  Diabet Med       Date:  1997       Impact factor: 4.359

3.  How useful are models of natural history in clinical decision making and clinical research?

Authors:  J R Beck; P T Scardino
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

4.  A diabetes report card for the United States: quality of care in the 1990s.

Authors:  Jinan B Saaddine; Michael M Engelgau; Gloria L Beckles; Edward W Gregg; Theodore J Thompson; K M Venkat Narayan
Journal:  Ann Intern Med       Date:  2002-04-16       Impact factor: 25.391

5.  Economic costs of diabetes in the US in 2002.

Authors:  Paul Hogan; Tim Dall; Plamen Nikolov
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

Review 6.  A systematic review of adherence with medications for diabetes.

Authors:  Joyce A Cramer
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  Costs and utilization associated with pharmaceutical adherence in a diabetic population.

Authors:  Kera L Hepke; Mary T Martus; David A Share
Journal:  Am J Manag Care       Date:  2004-02       Impact factor: 2.229

8.  Medication adherence and associated hemoglobin A1c in type 2 diabetes.

Authors:  Kimberley Krapek; Kathleen King; Susan S Warren; Karen G George; Dorothy A Caputo; Karen Mihelich; Elizabeth M Holst; Michael B Nichol; Sheng G Shi; Kevin B Livengood; Steve Walden; Teresa J Lubowski
Journal:  Ann Pharmacother       Date:  2004-07-06       Impact factor: 3.154

9.  Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis.

Authors:  Rajesh Balkrishnan; Rukmini Rajagopalan; Rahul A Shenolikar; Fabian T Camacho; J Timothy Whitmire; Roger T Anderson
Journal:  Curr Med Res Opin       Date:  2004-10       Impact factor: 2.580

10.  A general method of compliance assessment using centralized pharmacy records. Description and validation.

Authors:  J F Steiner; T D Koepsell; S D Fihn; T S Inui
Journal:  Med Care       Date:  1988-08       Impact factor: 2.983

View more
  38 in total

1.  Adherence to chronic disease medications among New York City Medicaid participants.

Authors:  Kelly A Kyanko; Robert H Franklin; Sonia Y Angell
Journal:  J Urban Health       Date:  2013-04       Impact factor: 3.671

2.  Adherence to medication regimens among low-income patients with multiple comorbid chronic conditions.

Authors:  Shiraz I Mishra; Deborah Gioia; Saltanat Childress; Beth Barnet; Ramothea L Webster
Journal:  Health Soc Work       Date:  2011-11

3.  Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end stage renal disease.

Authors:  Ebele M Umeukeje; Joseph R Merighi; Teri Browne; Marcus Wild; Hafez Alsmaan; Kausik Umanath; Julia B Lewis; Kenneth A Wallston; Kerri L Cavanaugh
Journal:  J Behav Med       Date:  2016-05-11

4.  Caring by Numbers: Evaluation of Inconsistencies and Incompleteness in the Reporting of Racial and Ethnic Data.

Authors:  Beth Marie Hartzler; Angela Snyder
Journal:  J Racial Ethn Health Disparities       Date:  2017-03-08

5.  How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.

Authors:  Thomas Wilke; Antje Groth; Sabrina Mueller; Dallas Reese; Roland Linder; Susanne Ahrens; Frank Verheyen
Journal:  Eur J Health Econ       Date:  2012-07-20

6.  Predictors of continuous positive airway pressure use during the first week of treatment.

Authors:  Lichuan Ye; Allan I Pack; Greg Maislin; David Dinges; Sharon Hurley; Susan McCloskey; Terri E Weaver
Journal:  J Sleep Res       Date:  2011-10-11       Impact factor: 3.981

7.  Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease.

Authors:  Ebele M Umeukeje; Joseph R Merighi; Teri Browne; Jacquelyn N Victoroff; Kausik Umanath; Julia B Lewis; T Alp Ikizler; Kenneth A Wallston; Kerri Cavanaugh
Journal:  J Ren Nutr       Date:  2015-04-22       Impact factor: 3.655

8.  Appointment adherence and disparities in outcomes among patients with diabetes.

Authors:  Joel M Schectman; John B Schorling; John D Voss
Journal:  J Gen Intern Med       Date:  2008-07-26       Impact factor: 5.128

9.  ACE inhibitor and ARB medication use among Medicaid enrollees with diabetes.

Authors:  Claudia M Lora; Alexander W Sokolovsky; Daniel R Touchette; Jing Jin; Xiaojing Hu; Weihua Gao; Ben S Gerber
Journal:  Ethn Dis       Date:  2013       Impact factor: 1.847

10.  The Aston Medication Adherence Study: mapping the adherence patterns of an inner-city population.

Authors:  Christopher A Langley; Joseph Bush
Journal:  Int J Clin Pharm       Date:  2013-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.